MediWound (MDWD) Common Equity (2013 - 2026)

MediWound has reported Common Equity for 14 years, with the latest figure at $35.6 million in Q2 2026.

• On a quarterly basis, Common Equity rose 77.17% year-over-year to $35.6 million in Q2 2026; TTM through Jun 2026 was $35.6 million, a 77.17% increase from a year earlier, with the FY2025 full-year figure at $43.6 million, up 40.06% from the prior year.
• Common Equity was $35.6 million for Q2 2026 at MediWound, down from $41.4 million in the prior quarter.
• The five-year high for Common Equity was $50.2 million in Q3 2025, with the low at -$2.2 million in Q2 2022.
• Average Common Equity over 5 years is $26.3 million, with a median of $31.4 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Common Equity tumbled 205.52% in 2022, then surged 1895.77% in 2023.
• Over 5 years, Common Equity stood at $10.9 million in 2022, then surged by 189.49% to $31.6 million in 2023, then dropped by 1.4% to $31.2 million in 2024, then surged by 40.06% to $43.6 million in 2025, then dropped by 18.31% to $35.6 million in 2026.
• The last three Common Equity figures came in at $35.6 million (Q2 2026), $41.4 million (Q1 2026), and $43.6 million (Q4 2025), per Business Quant data.